Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Nuclera secures £1.14M in Innovate UK grants for eProtein Discovery platform
, /in E-News /by panglobalUK-based biotechnology firm Nuclera has been awarded two Innovate UK grants totalling £1.14 million to further develop its eProtein Discovery system. The funding comprises a £790,000 flexible, agile, scalable, and sustainable technologies (FASST) grant and a £350,000 Engineering Biology grant.
Swiss CDMO expands biologics development capabilities
, /in E-News /by panglobalThe Celonic Group, a Swiss-based contract development and manufacturing organisation (CDMO) specialising in quality biologics, has inaugurated its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland. This expansion aims to support pharmaceutical companies in developing and optimising processes using advanced bioprocessing technologies.
SGS expands biopharmaceutical stability testing services in Switzerland
, /in E-News /by panglobalSGS, a leading provider of biopharmaceutical testing services, has announced the expansion of its laboratory in Birsfelden, Switzerland, to include stability studies. This addition to the facility’s service portfolio aims to meet the growing demand for comprehensive and reliable stability testing in the biopharmaceutical industry.
Strategic partnership to advance monoclonal antibody discovery
, /in E-News /by panglobalIcosagen, a contract research, development, and manufacturing organisation (CRDMO) specialising in innovative antibody research and production, has announced a strategic partnership with Lead Discovery Center GmbH (LDC), a translational drug discovery organisation. The collaboration aims to discover monoclonal antibody portfolios targeting therapeutically relevant proteins, including a pivotal G-protein coupled receptor (GPCR), which are often challenging […]
Vetter expands global manufacturing capacity for injectable therapeutics
, /in E-News /by panglobalLeading contract development and manufacturing organisation (CDMO) Vetter has announced significant expansion plans in both the United States and Germany, aiming to meet the growing demand for outsourced development and manufacturing of injectable medications.
ELRIG UK announces keynote speakers for Drug Discovery 2024
, /in E-News /by panglobalThe European Laboratory Research & Innovation Group (ELRIG) UK has revealed the keynote speakers for its flagship conference, Drug Discovery 2024. The event, scheduled for 2-3 October at ExCeL London, will feature presentations from two distinguished scientists in the field of pharmaceutical research and development.
The science of safety | Promoting ergonomic practices in the lab
, /in Featured Articles /by panglobalBy LaNiesha Littleton Repetitive manual tasks are common in many laboratories, making the risk of repetitive strain injuries and musculoskeletal disorders a significant concern for businesses and employees alike. This article highlights the importance of injury prevention through expert support and ergonomic solutions, and explores how the workplace health and safety landscape is now being […]
Insight into DNA methylation analysis
, /in Featured Articles, Molecular Diagnostics /by panglobalThe association of epigenetic changes with disease pathogenesis is the subject of much study. CLI caught up with Dr Kathleen Barnes (Oxford Nanopore Technologies) to find out more about how DNA methylation is linked to disease as well as developments in methods of DNA methylation analysis for improving disease diagnosis, prognostic stratification and therapy.
Using ferritin as a biomarker for hemophagocytic lymphohistiocytosis can reduce delays in treatment due to negative or pending hemophagocytosis results
, /in Featured Articles, Hematology & Flow Cytometry /by panglobalUsing ferritin as a biomarker for hemophagocytic lymphohistiocytosis can reduce delays in treatment due to negative or pending hemophagocytosis results
Molecular diagnosis of the myeloproliferative neoplasms
, /in Featured Articles, Molecular Diagnostics /by panglobalBy Dr Stephen Langabeer The myeloproliferative neoplasms of polycythemia vera, essential thrombocythemia and primary myelofibrosis are clonal hematopoietic disorders characterized by an over-production of mature blood cells. Molecular evaluation is a key component of differentiating malignancy from a host of reactive causes with mutations in JAK2, CALR and MPL genes present in the majority of […]